^
    almost3years
    BGI obtains SFDA approval for its gene annotation software and detection kit on non-small cell lung cancer (BGI Group Press Release)
    "BGI Genomics announces that its Non-small Cell Lung Cancer Mutation Analysis Software and EGFR/KRAS/ALK Gene Mutation Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method) have been approved by the Saudi Food and Drug Authority (SFDA)...BGI’s mutation analysis software and detection kit offer a comprehensive solution for detecting NSCLC, allowing clinicians to diagnose timely and provide patients with effective treatment options."
    Non-US regulatory
    |
    EGFR/KRAS/ALK Gene Mutation Detection Kit